EXAS vs GENK · rev $2.76B vs rev $212.5M
EXACT Sciences Corporation (EXAS) versus GEN Restaurant Group, Inc. Class A Common Stock (GENK) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
GEN Restaurant Group, Inc. Class A Common Stock (GENK) is a restaurants company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported GENK revenue for 2025-12-31 was $212.5M. Net income was -$3.0M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. GENK currently screens at market cap $63.6M.
EXAS currently screens at market cap $20.03B. GENK currently screens at market cap $63.6M.
Not investment advice. Open the EXAS and GENK stock pages for the full models.
Not investment advice.